Early BAFF receptor blockade mitigates murine Sjögren's syndrome Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction

Early BAFF receptor blockade mitigates murine Sjögren's syndrome : Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction

Copyright © 2016 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 164(2016) vom: 05. März, Seite 85-94
1. Verfasser: Sharma, Arjun (VerfasserIn)
Weitere Verfasser: Kiripolsky, Jeremy, Klimatcheva, Ekaterina, Howell, Alan, Fereidouni, Farzad, Levenson, Richard, Rothstein, Thomas L, Kramer, Jill M
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Autoantibody BAFF receptor CXCL13 Salivary hypofunction Sialadenitis Sjögren's syndrome Antibodies mehr... B-Cell Activation Factor Receptor Chemokine CXCL13 Cxcl13 protein, mouse Tnfrsf13c protein, mouse
Online verfügbar Volltext